Concepedia

Visterra (United States)

V(

Statistics

Publications

77

Citations

8.4K

Authors

6

Location

Cambridge, United States

Visterra (United States) is a company institution in Cambridge, United States known for medicine, immunology, and immunotherapy.

HomepageROR

Top concepts

Publications

77

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

Mohit Mathur, Jonathan Barratt, Bobby Chacko et al. · New England Journal of Medicine · 2023 · 166 citations · Full text

Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope

Luke N. Robinson, Kannan Tharakaraman, Kirk J. Rowley et al. · Cell · 2015 · 138 citations · Full text

Extending human IgG half-life using structure-guided design

Brian J. Booth, Boopathy Ramakrishnan, Kristin Narayan et al. · mAbs · 2018 · 107 citations · Full text

, , +26

A chemoselective strategy for late-stage functionalization of complex small molecules with polypeptides and proteins

Daniel T. Cohen, Chi Zhang, Colin M. Fadzen et al. · Nature Chemistry · 2018 · 100 citations

, , +10

BindCraft: one-shot design of functional protein binders

Martin Pačesa, Lennart Nickel, Christian Schellhaas et al. · 2024 · 95 citations · Full text

1–5 of 77

Authors

6

  1. AM
    Andrew M. Wollacott

    Visterra (United States), United States

    32 publications · 3.3K citations

    21

    h-index

  2. MM
    Mohit Mathur

    Visterra (United States), United States

    61 publications · 609 citations

    14

    h-index

  3. SS
    Susan Sloan

    Visterra (United States), United States

    24 publications · 1.6K citations

    14

    h-index

  4. CA
    Catherine A. Hay

    Visterra (United States), United States

    10 publications · 1.3K citations

    8

    h-index

  5. TK
    Tyree Koch

    Visterra (United States), United States

    6 publications · 225 citations

    3

    h-index

1–5 of 6